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Abstract
VAR2CSA mediates sequestration of Plasmodium falciparum-infected erythrocytes in the placenta, increasing the risk of poor
pregnancy outcomes. Naturally acquired antibodies (Ab) to placental parasites at delivery have been associated with
improved pregnancy outcomes, but Ab levels and how early in pregnancy Ab must be present in order to eliminate
placental parasites before delivery remains unknown. Antibodies to individual Duffy-binding like domains of VAR2CSA have
been studied, but the domains lack many of the conformational epitopes present in full-length VAR2CSA (FV2). Thus, the
purpose of this study was to describe the acquisition of Ab to FV2 in women residing in high and low transmission areas
and determine how Ab levels during pregnancy correlate with clearance of placental parasites. Plasma samples collected
monthly throughout pregnancy from pregnant women living in high and low transmission areas in Cameroon were
evaluated for Ab to FV2 and the proportion of high avidity Ab (i.e., Ab that remain bound in the presence of 3M NH4SCN)
was assessed. Ab levels and proportion of high avidity Ab were compared between women with placental malaria (PM
+)
and those without (PM
2) at delivery. Results showed that PM
2 women had significantly higher Ab levels (p=0.0047) and
proportion of high avidity Ab (p=0.0009) than PM
+ women throughout pregnancy. Specifically, women with moderate to
high Ab levels (.5,000 MFI) and those with $35% high avidity Ab at 5–6 months were found to have 2.3 (95% CI, 1.0–4.9)
and 7.6-fold (p=0.0013, 95% CI: 1.2–50.0) reduced risk of placental malaria, respectively. These data show that high levels of
Ab to FV2, particularly those with high avidity for FV2, produced by mid-pregnancy are important in clearing parasites from
the placenta. Both high Ab levels and proportion of high avidity Ab to FV2 may serve as correlates of protection for
assessing immunity against placental malaria.
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Introduction
Plasmodium falciparum infections increase the risk of maternal
anemia, delivery-related complications and poor pregnancy
outcomes [1–5]. A major reason for the severity of malaria during
pregnancy is the binding of infected erythrocytes (IE) via
VAR2CSA to chondroitin sulfate A (CSA) on syncytiotrophoblasts
and extracellular matrix in the intervillous space of the placenta
[6–9]. As a result, IE sequester in the placenta causing placental
malaria (PM). After one or more pregnancies, women develop
antibodies (Ab) to VAR2CSA that improve pregnancy outcomes,
including reduced risk of maternal anemia [10,11], low birth
weight babies [8,12], and placental parasitemia [13]. In vitro and ex
vivo studies show that naturally acquired Ab block IE from binding
to placenta tissue and CSA [14–16] and promote phagocytosis by
macrophages [17–19]; however, characteristics of the Ab response
required for women to clear placental parasites remains unclear. It
is also unknown how development of Ab to VAR2CSA differs
between women living in high versus low transmission areas.
Answers to these questions will provide crucial information for the
forthcoming VAR2CSA clinical trials and for assays to evaluate
protection from placental malaria.
In this study, the acquisition of Ab specific for full-length
VAR2CSA (FV2) was determined using plasma collected longi-
tudinally from women living in areas of high and low perennial
malaria transmission, prior to implementation of intermittent
presumptive treatment and insecticide-treated bednets. This is the
first study to report the natural acquisition of Ab to all Duffy-
binding like (DBL) domains, as previous studies have measured
either the binding of Ab to the surface of IE and/or to
recombinant DBL domains of VAR2CSA [20–24]. It is important
to examine naturally acquired Ab to FV2, since individual DBL
domains exhibit lower specificity and binding affinity for CSA
compared to full-length VAR2CSA [25,26]; while, measuring Ab
to the surface of IE is less specific compared to Ab responses to
recombinant FV2.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e40049In previous studies, an association between inhibition of binding
and clearance of parasites from the intervillous space of the
placenta was not found using serum samples collected at delivery
[27,28]. Here we sought to determine if Ab levels at the end of the
first, during the second, and/or third trimesters correlated with
clearance of placental infections by comparing the responses of
women who had placental malaria (PM
+) and those without (PM
2)
at delivery. Furthermore, since immune exposure to VAR2CSA is
primarily pregnancy-associated, the restricted exposure raises the
questions of whether and how soon women produce high avidity
Ab to VAR2CSA (i.e., Ab with strong-binding to FV2). High
avidity Ab resulting from affinity maturation are often correlated
with strong activities against viruses [29,30] and bacteria [31], as
well as protection from diseases [30]. It was recently reported that
individuals residing in malaria endemic areas with high affinity Ab
to P. falciparum merozoite surface protein-2 (MSP-2) had prolonged
periods without clinical malaria [32]. Accordingly, we also
investigated the importance of high avidity anti-VAR2CSA Ab
in clearing parasites of the placental phenotype.
Results
Description of Women
The composition of women in Ngali II (n=39) and Yaounde ´
(n=50) included in this study were similar with respect to age,
length of pregnancy, and proportion of primigravidae (Table 1).
Significantly more women in Ngali II became slide-positive during
pregnancy (p=0.01), but the prevalence of slide-positivity did not
differ significantly between the two sites when analyzed by
trimesters.
Acquisition of IgG to Full-length VAR2CSA
For ease, Ab responses were divided into four categories:
negative (below cut-off), low (above cut-off, but ,5,000 MFI),
intermediate (5,000–10,000 MFI) and high (.10,000 MFI).
Women with intermediate to high Ab levels were considered to
have strong Ab responses. Cut-off values were defined by the
mean+2 SD from corresponding endemic male controls (Fig. 1e–f).
Acquisition of Ab to FV2 differed in women living in Ngali II and
Yaounde ´ (Fig. 1). At 3 months of pregnancy, 28% of primigrav-
idae in Ngali II had Ab (Fig. 1a); whereas, none of the
primigravidae in Yaounde ´ were Ab-positive (Fig. 1b). By 4
months, 20% of primigravidae in Ngali II had developed strong
responses (i.e., MFI .5,000); whereas, almost none of the
primigravidae in Yaounde ´ developed strong responses prior to
delivery. Likewise, multigravidae in Ngali II had more rapid
responses than multigravidae in Yaounde ´ (Fig. 1c – d) and a
higher proportion of multigravidae in Ngali II produced strong Ab
responses at 6 (p,0.0001) and 8 months (p=0.0006) than
multigravidae in Yaounde ´. Clearly, malaria transmission strongly
influenced the acquisition of Ab to FV2.
The response to FV2 was predominantly pregnancy-associated
as adult males living in two sites had very low reactivity with FV2
(Fig. 1e–f). Only 1 of 40 (2.5%) males had intermediate Ab levels
and 6/40 (15%) had low levels at both sites. Thus, it is likely that
most pregnant women with low Ab to FV2 seroconverted during
pregnancy.
Correlation between Levels of Antibodies to FV2 and
Absence of Placental Malaria
Data on placental malaria status at delivery were available for
27/39 women in Ngali II and 48/50 in Yaounde ´. Characteristics
of this subgroup of women did not differ from those in Table 1. Ab
levels throughout the course of pregnancy were compared between
PM
+ and PM
2 women (Fig. 2) using multilevel polynomial
regression analysis. In Ngali II, Ab levels increased in a liner
fashion (p=0.0003) in both PM
2 and PM
+ women with both
groups having similar Ab levels by delivery (Fig. 2a). Notably,
PM
2 women had significantly higher Ab levels throughout the
course of pregnancy than PM
+ women (p=0.005). Since all PM
2
women were multigravidae, adjustment could not be made for
gravidity in the analysis across groups. However, within the PM
+
group, there was no significant difference in Ab levels to FV2
between primigravidae and multigravidae (p=0.54). Therefore,
the absence of PM at delivery in Ngali II correlated with Ab levels
over time.
In Yaounde ´, 23/48 women were PM
2 and failed to make Ab to
FV2 (data not shown). These women had detectable submicro-
scopic infections or very low parasitemia by microscopy, but they
did not produce Ab to FV2. Data from the remaining 25 women
who were seropositive for FV2 showed a similar trend to that
found in women living in Ngali II. PM
2 women in Yaounde ´ had
consistently higher levels of Ab compared to PM
+ women,
although the difference in this small group of women did not
reach statistical significance (Fig. 2b). Overall, the magnitude of
Ab response was lower in women living in Yaounde ´.
Placental malaria-negative women at both study sites were
exclusively multigravidae (i.e., $2 pregnancies). Accordingly, the
Ab responses of PM
+ women were analyzed by gravidity.
Longitudinal analysis showed no difference in Ab levels to FV2
between PM
+ primigravidae (PG) and PM
+ multigravidae (MG) at
both sites (Fig. 2c–d), although PM
+ MG had slightly higher Ab
levels than PM
+ PG at the earliest time-points in Ngali II. Thus,
our data suggest that regardless of transmission intensity,
primigravid women are at an increased risk of placental malaria
at delivery due to the lack of anti-FV2 Ab prior to 7 months of
pregnancy. Even though some primigravidae produced Ab levels
comparable to PM
2 MG by 8 months of pregnancy, the Ab
response probably occurred too late to clear parasites from the
placenta before delivery. Equally interesting, our data also
illustrate that some multigravid women living in either the high
or low transmission sites remained susceptible to placental malaria
because they did not produce high levels of Ab to FV2 early in
Table 1. Characteristics of women followed longitudinally
Ngali II Yaounde ´ p values
Number of women 39 50
Age (years) 23.265.4
a 25.065.1 0.117
Length of pregnancy (weeks) 39.062.5
a 39.561.7 0.312
Primigravidae (%) 33.3% 34.0% 1.000
Proportion of women who were
Slide-positive 1 or more times
b 79.5% 54.0% 0.01
PCR-positive one or more times
b 100% 100%
Percent (%) Slide positivity at
3 Months of Pregnancy 36.8% 14.0% 0.087
4–6 Months of Pregnancy 36.3% 23.4% 0.299
7–9 Months of Pregnancy 34.6% 21.6% 0.197
Placental malaria-positive 51.9% 31.3% 0.090
a mean 6 SD.
b samples were selected from women who were slide and/or PCR-positive at
least once during pregnancy confirming that women had become infected.
doi:10.1371/journal.pone.0040049.t001
Antibodies to Full-Length VAR2CSA
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st through the 2
nd trimester
appear to be a primary determinant of placental malaria status.
To further dissect when during pregnancy strong Ab responses
correlated with absence of placental malaria, mean Ab levels in
plasma of women in Ngali II were evaluated at two-month
intervals (i.e., 3–4, 5–6, and 7–8 months of pregnancy) with
respect to placental malaria status at delivery. Women with
intermediate to high anti-FV2 Ab levels (MFI .5,000) at 5–6
months and 7–8 months had 2.3 (95% CI, 1.02–4.94; p=0.05)
and 2.0 times (95% CI, 1.01–3.93; p=0.10), respectively,
decreased risk of placental malaria at delivery compared to
women with ,5,000 MFI anti-FV2 Ab. In summary, higher Ab
levels to FV2 correlated with absence of placental malaria.
Correlation between Infected Erythrocyte Surface
Staining and Absence of Placental Malaria
Ab binding to the surface of placental type IE was evaluated by
flow cytometry (Fig. 2e). Antibodies targeting the surface of CSA-
adhering IE (7G8 strain) were significantly higher in PM
2 than
PM
+ women (p=0.05) (Fig. 2e). The level of surface binding
increased linearly from 4 to 7 months in PM
2 women; whereas, in
PM
+ women levels remained low and only increased during the
third trimester. Overall, similar results were obtained in assays
measuring Ab to FV2 and binding to the surface of IE.
Figure 1. Natural Acquisition of IgG Antibodies to VAR2CSA. (a–d) Ab levels to FV2 were determined using plasma from (a, b) primigravidae
and (c, d) multigravidae in Ngali II and Yaounde ´. The total number of samples evaluated per month ranged from 19–37 for Ngali II and 39–46 for
Yaounde ´. Ab levels were divided into 4 categories: negative (white; below cutoff: the mean +2 SD of adult males in the same site), low (grey; above
cutoff, but ,5000 MFI), intermediate (checkered; 5,000–10,000 MFI) and high (black; .10,000 MFI). The percentage of women within each Ab group
is shown. Women with Ab levels $5,000 MFI were considered to have strong Ab responses. (e–f) In comparison to pregnant women, only 1/40 male
who lived in the two study sites had intermediate and 6/40 had low Ab levels to FV2. Antibody cutoff values for Ngali II and Yaounde ´ women were
2756 and 1192 MFI, respectively.
doi:10.1371/journal.pone.0040049.g001
Antibodies to Full-Length VAR2CSA
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Antibodies to Full-length VAR2CSA and Absence of
Placental Malaria
To elucidate if anti-FV2 Ab quality is important in parasite
clearance, the proportion of high avidity Ab to FV2 (i.e., Ab
remaining bound after treatment with 3M NH4SCN) was
determined in plasma from women in Ngali II (Fig. 3) and the
women in Yaounde ´ (n=25) who were seropositive to FV2. This
analysis showed that very few women in Yaounde ´ developed high
avidity Ab, preventing further analysis. By comparison, in Ngali II
during the first trimester none of the Ab in primigravidae were
high avidity. However, by delivery 17.863.9% (mean 6 SEM) of
anti-FV2 Ab were found to be high avidity (Fig. 3a). Furthermore,
during the first trimester, 28.465.0% of anti-FV2 Ab in
multigravidae were high avidity, and this increased to
40.162.1% during the third trimester. As expected, the propor-
tion of high avidity Ab was higher throughout pregnancy in
multigravidae compared to primigravidae (p,0.0001; multilevel
polynomial regression analysis). Thus, the development of high
avidity anti-FV2 Ab is gravidity-related. Importantly, the propor-
tion of high avidity Ab was significantly higher in PM
2 compared
to PM
+ women throughout pregnancy (p=0.0009) (Fig. 3b). That
is, the proportion of high avidity Ab in PM
2 women rose from
34612% at 3 months to 42615% at 5 months, and plateaued at
43% until term. In contrast, in PM
+ women, only 16618% of Ab
were high avidity at 3 months, 23616% at 6 months, and
33612% at the end of pregnancy. Although the proportion of
high avidity Ab was generally higher in multigraivd compared to
primigravid women, some multigravidae still had placental
malaria, suggesting high avidity Ab may be needed early in
Figure 2. Correlation between Antibody Levels to VAR2CSA and Placental Malaria at Delivery. Anti-FV2 Ab levels (MFI 6 SEM) were
determined between 3 to 9 months of pregnancy in women in Ngali II (a) and Yaounde ´ (b) with known placental malaria status (Ngali II: PM
2 n=13,
PM
+ n=14; Yaounde ´:P M
2 n=10, PM
+ n=15). (a) A significant difference between PM
2 and PM
+ women in Ngali II was found throughout pregnancy
using multilevel polynomial regression analysis (p=0.0047). (b)P M
2 women in Yaounde ´ also had higher mean Ab levels compared to PM
+ women,
although difference was not significant. (c–d) Data from PM
2 and PM
+ women were subdivided into primigravidae (PG) and multigravidae (MG). All
PG in Ngali II and Yaounde ´ were PM
+ at delivery, explaining why there are only 3 groups in the figures. Similar Ab levels were present in placental PM
+
PG and PM
+ MG. (e) The same plasma samples from PM
2 and PM
+ women in Ngali II collected at 4 to 7 months were tested for surface binding to
CSA-binding IE (7G8 strain). In support of the results in Fig. 2a, higher levels of Ab was detected in women in Ngali II who were PM
2 compared to
those who were PM
+ (p=0.05). P values are based on multilevel polynomial regression analysis. Abbreviations: FV2, full-length VAR2CSA; PM
2,
placental malaria-negative; PM
+, placental malaria-positive; PG, primigravidae; MG, multigravidae.
doi:10.1371/journal.pone.0040049.g002
Antibodies to Full-Length VAR2CSA
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proportion of high avidity anti-FV2 Ab at 5–6 months of
pregnancy was significantly associated with absence of placental
malaria (p,0.0001). While PM
2 women still had higher
proportion of high avidity Ab at 3–4 and 7–8 months of
pregnancy, the differences at these time points were not significant
(Fig. 3c). Moreover, women in Ngali II with $ 35% high avidity
Ab during the 5–6 months of pregnancy had a 7.6 times (95% CI:
1.2–50.0; p=0.0013) lower risk of placental malaria than women
with ,35% high avidity Ab. In Yaounde ´, the number of women
with high avidity Ab was too small for accurate correlation analysis
and therefore data are not shown. Thus, at least in the high
transmission setting, high avidity Ab to FV2 by the 2
nd trimester
was found to be important in reducing placental malaria by
delivery.
Discussion
Antibodies that bind to CSA-adhering IE and different DBL
domains of VAR2CSA have been associated with improved
pregnancy outcomes [8,10–12]. Nonetheless, in previous studies
Ab levels at delivery were not found to differ between PM
2 and
PM
+ women [13,33]; in fact, higher levels were often associated
with active or chronic placental malaria [16,22]. In the current
study, Ab levels to FV2 were significantly higher from early (3–4
months) in pregnancy until term in PM
2 compared to PM
+
women (Fig. 2a). Likewise, significantly increased binding of Ab to
the surface of IE was observed in PM
2 women (Fig. 2e). Strong Ab
responses to FV2 (i.e., .5,000 MFI) at 5–6 and 7–8 months of
pregnancy reduced a woman’s risk of having placental malaria 2.3
and 2.0 fold, respectively. Since Ab levels increased during
pregnancy (Fig. 1 and Fig. 2), these data help explain the
previously reported lack of association between Ab at delivery and
absence of placental malaria.
Although the above association was only statistically significant
in the high transmission rural village where women were
repeatedly infected [34], the same trend was observed in women
living in the low transmission urban city. These results agree with
our understanding of infection with VAR2CSA-expressing para-
sites in that Ab responses to VAR2CSA were low or absent early
in pregnancy, increased progressively over the course of pregnan-
cy, and were higher following several pregnancies. Overall, these
findings suggest that protection from placental malaria correlates
with the acquisition of a mature humoral immune response
starting during the first half of pregnancy. Previous results showed
that the breadth of the Ab response to the 6 DBL domains
increases during pregnancy and a broader repertoire was
associated with clearance of placental parasites [35]. The current
results show that the magnitude and avidity of anti-VAR2CSA Ab
continue to evolve over multiple pregnancies and are positively
associated with malaria transmission intensity and clearance of
placental parasites. Therefore, the overall ‘‘quality’’ of anti-
Figure 3. High Avidity Antibodies to VAR2CSA were Associated with Absence of Placental Malaria in Ngali II. (a) The proportion (%) of
Ab that remains bound to FV2 after incubation with 3M NH4SCN (i.e., % high avidity Ab) in the plasma of primigravidae and multigravidae living in
Ngali II is shown. Results represent the mean + SEM for 11 to 51 data points per bar. Throughout the course of pregnancy, the proportion of high
avidity Ab to FV2 was higher in multigravid than primigravid women (p,0.0001; multilevel polynomial regression analysis). (b) The scattergram
shows that the proportion of high avidity Ab to FV2 was highly variable. However, the proportion (%) of high avidity Ab in plasma of women who
were PM
2 was significantly higher than in plasma of PM
+ women during pregnancy (PM
2, n=13; PM
+, n=14) (p=0.0009), based on multilevel
polynomial regression analysis. (c) A significantly higher proportion of high avidity Ab was present in plasma of PM
2 women than PM
+ women at 5–6
months (p,0.0001), but not at 3–4 and 7–8 months.
doi:10.1371/journal.pone.0040049.g003
Antibodies to Full-Length VAR2CSA
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malaria transmission intensity.
This study suggests that primigravidae are most likely highly
susceptible to placental malaria as they lack high levels of Ab to
VAR2CSA during the 1
st and 2
nd trimesters. Of interest, 66% of
primigravid women in Ngali II failed to develop strong Ab
responses to FV2 (FCR3 allele), despite being repeatedly infected
during pregnancy. In Ngali II, some multigravid women had
placental malaria at delivery and they also had lower Ab levels to
FV2. Whether this reflects gaps in the antibody repertoire to
achieve adequate Ab breadth [35] or additional factors that
control immune responsiveness to placental isolates such as
parasites having multiple var2csa copies [36] should be investigat-
ed.
The comparison of women in the city further highlights that
malaria transmission intensity has a profound effect on the
maturation of the anti-VAR2CSA antibody response. In Yaounde ´,
only 33% of primigravidae had Ab responses to FV2 at delivery
and only 18% of multigravidae developed strong Ab responses to
the antigen (Fig. 1). All of the women were either slide- or PCR-
positive prior to 6 months of pregnancy, showing that lack of a
response was not due to lack of infection (Table 1). It is possible
that Ab to other malarial antigens eliminated IE before the
parasite expressed the CSA-binding phenotype and sequestered in
the placenta, in which case a humoral immune response to
VAR2CSA would not have been induced. The combined results
from both transmission settings emphasize that development of a
vaccine should not only target primigravid women, but women of
all gravidities, especially with the changing epidemiological profile
of malaria in Africa.
Taken together, our data demonstrate that women who
possessed high levels of Ab to FV2, especially those with high
avidity, early in pregnancy are likely to be free of placental malaria
at delivery. These antibody responses developed better in women
from the higher malaria transmission setting, indicating that
malaria transmission intensity influences the evolution of protec-
tive anti-VAR2CSA antibodies. While we could only use placental
malaria status at delivery as a direct outcome measure of Ab to
VAR2CSA, it is important to point out that the process of parasite
clearance occurred over time during pregnancy. The sooner a
woman eliminates malaria parasites from the intervillous space,
the better it is for the pregnancy. Thus, vaccines for VAR2CSA
should aim to induce high levels of anti-VAR2CSA Ab spanning
the entire course of pregnancy. These results are encouraging as
they substantiate the important role of anti-VAR2CSA Ab in the
clearance of IE from the placenta.
Materials and Methods
Study Sites
A prospective cohort study was conducted between 2001 and
2005 in the rural village of Ngali II and in the city of Yaounde ´,
Cameroon, where malaria transmission is perennial and individ-
uals receive approximately 256 and 13 infectious bites/person/
year, respectively [34,37].
Study Populations
Women were recruited at government-operated facilities during
the first trimester and written informed consent was obtained. At
enrollment, malaria histories were recorded and peripheral blood
samples collected. Participants were followed monthly, at which
time information on their health and anti-malarial drug usage
were recorded and peripheral blood samples were collected.
Women who became blood-smear positive for P. falciparum were
prescribed anti-malarial drugs and iron-supplement according to
the government policy. At delivery, information on delivery
outcome and the neonate was recorded, and samples of maternal
peripheral blood, placental blood, and a biopsy of placental tissue
were collected for parasitological evaluation. Chloroquine was the
first line antimalarial when the study began, but due to increasing
resistance, artemisinin in combination with amodiaquine were
adopted during the last year of sample collection in the 2004.
None of the women were prescribed antimalarial drugs within
5 weeks of delivery. The prevalence of HIV seropositivity was
,9% at the time of the study. The study was completed before the
implementation of intermittent preventive treatment and bednets
in Cameroon. All participants gave written informed consent. The
study was approved by the National Ethics Committee, Cameroon
and the Institutional Review Board, Georgetown University. Use
of the coded archived samples and data in the current study was
exempted from human subject research by the Committee on
Human Studies, University of Hawai’i, Ma ¯noa, USA.
Diagnosis of Malaria
Blood smears were prepared using maternal blood collected
monthly and at delivery. In addition, smears of blood from the
intervillous space and impression smears of the placental biopsy
were made. Slides were stained with Diff-Quick and read by two
microscopists for parasitemia. PCR was used to identify submi-
croscopic infections [38,39]. A woman was considered to have
placental malaria if IE were detected in placental blood or
impression smears.
Sample Selection
Plasma from all women who met the following criteria were
used: information was available on the woman’s age, gravidity,
and malarial status during pregnancy; confirmed malaria infection
detected by microscopy or PCR no later than six months of
pregnancy; and $4 samples collected throughout pregnancy. In
addition, plasma from 20 adult males living at each site was used
in the serological assays.
Expression of Recombinant Proteins
Full-length VAR2CSA was produced in Sf9 insect cells using
the baculovirus transfer vector. In brief, the var2csa sequence
(FCR3 strain, accession number GU249598) was inserted into the
Baculovirus transfer vector pAcGP67-A (BD Biosciences) with a
histidine tag on the C-terminal end. Linearized Bakpak6
Baculovirus DNA (BD Biosciences) was co-transfected with
pAcGP67-A into Sf9 insect cells for generation of recombinant
virus particles. Histidine-tagged recombinant protein was purified
on Ni
2+-Sepharose columns from the supernatant of Baculovirus
infected High-Five insect cells using an A ¨KTA-express purification
system (GE-Healthcare). Detailed information on expression and
characterization of FV2 protein was previously published [26].
IgG Antibodies to Full-length Recombinant VAR2CSA
IgG levels to FV2 were measured using the bead-based
immunoassay. In brief, saturating amounts (3mg) of recombinant
FV2 was covalently coupled to 1 million SeroMAP beads
(Luminex Corp.) at pH 7 [40]. The beads were blocked with
1% bovine serum albumin (BSA) in phosphate buffered saline
(PBS), pH 7.0 for 24 hr. For Ab measurements, 50ml of plasma
diluted to 1:500 was incubated with 3,000 FV2-coupled beads on a
titer plate shaker for 1 hr at room temperature (RT). After
washings with 1% BSA-PBS, 100ml of R-phycoerythrin-conjugat-
ed affinity purified F(ab’)2 goat anti-human IgG (Fcc specific)(-
Antibodies to Full-Length VAR2CSA
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for 1 hr. After washing, median fluorescence intensities (MFI) for
$100 beads were obtained using a LiquiChip 100 analyzer
(Luminex Corp.).
Percentage of Strong Binding (High Avidity) IgG to Full
Length VAR2CSA
We used a modified ammonium thiocyanate (NH4SCN) elution
protocol [41,42] and assessed the amount of Ab that remained
bound to FV2 after 30 min of incubation with 3M NH4SCN (i.e.,
high avidity Ab). Our approach aimed to determine the
proportion of FV2-specific Ab that were of high avidity, rather
than the average affinity of the heterogenous Ab pool in each
plasma sample. To minimize the effect of Ab concentration on Ab
avidity assessment, the proportion of high avidity anti-FV2 Ab was
determined using three plasma dilutions spread over the linear
range of detection. Then, the mean proportion of high avidity Ab
from all three measurements for each sample was determined. In
brief, each plasma sample was diluted to 1:300, 1:1,000 and
1:3,000 with 1% BSA-PBS and 50ml of each dilution was
incubated with 3,000 FV2-coupled beads as described above.
After washing, bead-Ab complexes were incubated for 30 min
with 100ml of PBS or 3M NH4SCN before R-phycoerythrin-
conjugated goat-anti-human IgG (Fcc specific) was added to beads
for 1 hr incubation. Percentage of high avidity Ab was calculated
by [MFI beads with NH4SCN]/[MFI beads with PBS] x100 and
the results from the three dilutions averaged. With this protocol,
only a minor variation among the three plasma dilutions was
found for the same sample. From assaying over 170 samples, the
inter-sample mean standard deviation (SD) is 64.8% and median
SD is 63.8%.
Antibody Binding to the Surface of Infected Erythrocytes
The protocol of Avril et al. was followed [43]. In brief, CSA-
binding IE (7G8 strain) were obtained by panning on CSA [44].
Plasma samples were preadsorbed twice with O
+ erythrocytes.
Then, 10 million erythrocytes with 5–8% trophozoites were
incubated with a 1:10 dilution of plasma, followed by FITC-
conjugated goat (Fab’)2 anti-human IgG (1:100 dilution,
PNIM1627, Beckman), evaluated using a LSRII flow cytometer
(Becton Dickinson), and data were analyzed using FLOWJO 8.1
software (Tree Star, Inc). Results are expressed as the mean of the
adjusted geometric MFI for plasma in duplicate. The adjusted
MFI = (IEt-UEt) – (IEc–UEc); where IEt = MFI of IE incubated
with test human plasma; UEt = MFI of uninfected erythrocytes
incubated with test human plasma; IEc= MFI of IE incubated
with USA control plasma; UEc = MFI of uninfected erythrocytes
incubated with USA control plasma.
Statistical Analysis
The Student t-test (unpaired) was used to compare age and
length of pregnancy between women in the 2 study sites. Fisher’s
exact test was used to compare the proportion of women who were
slide- and PCR-positive during pregnancy, proportion of Ab
responders between sites and the significance of relative risk
assessment. FV2 Ab levels and high avidity Ab in PM
2 and PM
+
women were analyzed using multilevel polynomial regression
analysis. In this analysis, longitudinal FV2 Ab levels and
percentage of high avidity Ab were dependent variables, while
placental malaria status, month of pregnancy (linear and
quadratic), and the interaction between malaria status and time,
were independent variables. Results with p values #0.05 were
considered to be significant.
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